DBX vs PATH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

DBX

33.6
AI Score
VS
PATH Wins

PATH

38.1
AI Score

Investment Advisor Scores

DBX

34score
Recommendation
AVOID NEW MONEY

PATH

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric DBX PATH Winner
Forward P/E 10.846 16.7224 DBX
PEG Ratio 27.1157 0.4777 PATH
Revenue Growth 0.9% 13.4% PATH
Earnings Growth -6.7% 2280.8% PATH
Tradestie Score 33.6/100 38.1/100 PATH
Profit Margin 17.5% 21.0% PATH
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

DBX 1M: +10.0% · 3M: +28.9% PATH 1M: +6.9% · 3M: +28.6%

Current Technical Phase

DBX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 65

RSI (14): 65.2 · Price: $37.63

PATH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.7 · Price: $13.94

Fundamentals Snapshot

Metric DBX PATH
Market Cap — —
Forward P/E 11.4 18.3
Trailing P/E 20.1 20.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.8%
Operating Margin 0.3% 0.1%
EPS 1.82 0.67
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PATH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.